ViewpointsOpinionBioNTech’s 30 Billion ReasonsSaveMark Us Preferred on GooglePrintA vial and syringe are seen in front of the Pfizer and BioNTech logos in a file photo. Dado Ruvic/ReutersRobert Kogon5/4/2023|Updated: 5/4/20230:00X 1CommentaryThe real winner in the COVID-19 vaccine sweepstakes is the German company BioNTech, not Pfizer.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.